Alaunos Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $36.8M | $94.9M | $76.1M |
| FY2022 | $26.4M | $64.9M | $39.1M |
| FY2023 | $2.0M | $8.3M | $6.1M |
| FY2024 | $692.0K | $2.8M | $1.1M |
| FY2025 | $813.0K | $3.0M | $1.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $36.8M | $94.9M | $76.1M |
| FY2022 | $26.4M | $64.9M | $39.1M |
| FY2023 | $2.0M | $8.3M | $6.1M |
| FY2024 | $692.0K | $2.8M | $1.1M |
| FY2025 | $813.0K | $3.0M | $1.4M |